Congratulations to our client Chemomab Therapeutics (“Chemomab”) on completing a merger with public company Anchiano Therapeutics. The combined company now goes by Chemomab Therapeutics Ltd. and is traded on Nasdaq
Continue Reading Congratulations to GT Client Chemomab on Recent Merger
Congratulations to our longstanding client, Enlivex Therapeutics Ltd. (“Enlivex”, NASDAQ: ENLV), which recently announced the successful completion of a $51.3 million offering of its Ordinary Shares. Leading the transaction on
Continue Reading Congratulations to longstanding GT Client Enlivex on Completing Multi-Million Dollar Offering